Skip to main content
Search
Search
    Quick Search anywhere
    Quick search in Citations
Advanced Search
Skip main navigationClose Drawer MenuOpen Drawer Menu
Previous article
Next article
Research Trends

Suicide Rates and Prescription of Antidepressants

Trends in the United States, 1999–2020, by Sex and Race/Ethnicity

Published Online:February 14, 2024https://doi.org/10.1027/0227-5910/a000941

Abstract

Abstract:Background: Previous ecological studies reported that increasing antidepressant prescriptions were associated with decreasing suicide rates. Aim: To determine whether antidepressant prescription prevalence is negatively associated with suicide rates (i.e., as antidepressant prescribing increases, suicide rates decrease) between 1999 and 2020. Method: The study protocol was pre-registered on the Open Science Framework (https://osf.io/978sk/). Publicly available data from the Centers for Disease Control and Prevention’s Wide-Ranging Online Data for Epidemiological Research (CDC WONDER) and Medical Expenditure Panel Survey (MEPS) were used. Results: Overall, both the antidepressant prescription prevalence and the suicide rate were increasing from 1990 to 2020 in the United States. Positive trends for both outcomes were also evident when analyses were stratified according to sex and/or race/ethnicity. Pearson’s correlation analyses consistently found positive associations between antidepressant prescription prevalence and suicide rates. Limitations: Trends and their associations were examined at the population level. The results cannot clarify the causal nature of the association observed. Conclusion: The results of our analysis consistently demonstrated positive trends for both antidepressant prescription prevalence and suicide rates over time as well as positive associations between them. These findings update those from previous studies and are at odds with the notion that, at a population level, more antidepressant prescriptions would lead to lower suicide rates. However, it needs to be acknowledged that ecological studies provide insufficient evidence to infer causality.

References

  • Amendola, S., Plöderl, M., & Hengartner, M. P. (2021). Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates? European Journal of Public Health, 31(2), 291–297. 10.1093/eurpub/ckaa204 First citation in articleCrossref Medline, Google Scholar

  • Baldessarini, R. J., Lau, W. K., Sim, J., Sum, M. Y., & Sim, K. (2017). Suicidal risks in reports of long-term controlled trials of antidepressants for major depressive disorder II. International Journal of Neuropsychopharmacology, 20(3), 281–284. 10.1093/ijnp/pyw092 First citation in articleCrossref Medline, Google Scholar

  • Baldessarini, R. J., Tondo, L., Strombom, I. M., Dominguez, S., Fawcett, J., Licinio, J., Oquendo, M. A., Tollefson, G. D., Valuck, R. J., & Tohen, M. (2007). Ecological studies of antidepressant treatment and suicidal risks. Harvard Review of Psychiatry, 15(4), 133–145. 10.1080/10673220701551102 First citation in articleCrossref Medline, Google Scholar

  • Braun, C., Bschor, T., Franklin, J., & Baethge, C. (2016). Suicides and suicide attempts during long-term treatment with antidepressants: A meta-analysis of 29 placebo-controlled studies including 6,934 patients with major depressive disorder. Psychotherapy and Psychosomatics, 85(3), 171–179. 10.1159/000442293 First citation in articleCrossref Medline, Google Scholar

  • Dahlberg, M., & Lundin, D. (2005). Antidepressants and the suicide rate: Is there really a connection? Advances in Health Economics and Health Services Research, 16, 121–141. 10.1016/S0731-2199(05)16006-3 First citation in articleCrossref Medline, Google Scholar

  • Grunebaum, M. F., Ellis, S. P., Li, S., Oquendo, M. A., & Mann, J. J. (2004). Antidepressants and suicide risk in the United States, 1985–1999. Journal of Clinical Psychiatry, 65(11), 1456–1462. 10.4088/jcp.v65n1103 First citation in articleCrossref Medline, Google Scholar

  • Gusmao, R., Quintao, S., McDaid, D., Arensman, E., Van Audenhove, C., Coffey, C., Varnik, A., Varnik, P., Coyne, J., & Hegerl, U. (2013). Antidepressant utilization and suicide in Europe: An ecological multi-national study. PLoS ONE, 8(6), Article e66455. 10.1371/journal.pone.0066455 First citation in articleCrossref, Google Scholar

  • Hedegaard, H., Curtin, S. C., & Warner, M. (2018). Suicide mortality in the United States, 1999–2017. National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db330.htm First citation in articleGoogle Scholar

  • Hengartner, M. P., Amendola, S., Kaminski, J. A., Kindler, S., Bschor, T., & Plöderl, M. (2021). Suicide risk with selective serotonin reuptake inhibitors and other new-generation antidepressants in adults: A systematic review and meta-analysis of observational studies. Journal of Epidemiology and Community Health, 75(6), 523–530. 10.1136/jech-2020-214611 First citation in articleCrossref, Google Scholar

  • Hengartner, M. P., & Plöderl, M. (2019). Newer-Generation antidepressants and suicide risk in randomized controlled trials: A re-analysis of the FDA database. Psychotherapy and Psychosomatics, 88(4), 247–248. 10.1159/000501215 First citation in articleCrossref Medline, Google Scholar

  • Huikari, S., Miettunen, J., & Korhonen, M. (2019). Economic crises and suicides between 1970 and 2011: Time trend study in 21 developed countries. Journal of Epidemiology and Community Health, 73(4), 311–316. 10.1136/jech-2018-210781 First citation in articleCrossref Medline, Google Scholar

  • Isacsson, G., Rich, C. L., Jureidini, J., & Raven, M. (2010). The increased use of antidepressants has contributed to the worldwide reduction in suicide rates. British Journal of Psychiatry, 196(6), 429–433. 10.1192/bjp.bp.109.076166 First citation in articleCrossref Medline, Google Scholar

  • Kim, H. J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000). Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine, 19(3), 335–351. 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z First citation in articleCrossref Medline, Google Scholar

  • Kim, H.-J., Fay, M. P., Yu, B., Barrett, M. J., & Feuer, E. J. (2004). Comparability of segmented line regression models. Biometrics, 60(4), 1005–1014. 10.1111/j.0006-341X.2004.00256.x First citation in articleCrossref Medline, Google Scholar

  • Luo, F., Florence, C. S., Quispe-Agnoli, M., Ouyang, L., & Crosby, A. E. (2011). Impact of business cycles on US suicide rates, 1928-2007. American Journal of Public Health, 101(6), 1139–1146. 10.2105/AJPH.2010.300010 First citation in articleCrossref Medline, Google Scholar

  • Mann, J. J., Apter, A., Bertolote, J., Beautrais, A., Currier, D., Haas, A., Hegerl, U., Lonnqvist, J., Malone, K., Marusic, A., Mehlum, L., Patton, G., Phillips, M., Rutz, W., Rihmer, Z., Schmidtke, A., Shaffer, D., Silverman, M., Takahashi, Y., … Hendin, H. (2005). Suicide prevention strategies: A systematic review. JAMA, 294(16), 2064–2074. 10.1001/jama.294.16.2064 First citation in articleCrossref Medline, Google Scholar

  • Miron, O., Yu, K. H., Wilf-Miron, R., & Kohane, I. S. (2019). Suicide rates among adolescents and young adults in the United States, 2000–2017. JAMA, 321(23), 2362–2364. 10.1001/jama.2019.5054 First citation in articleCrossref Medline, Google Scholar

  • National Cancer Institute. (2022). Joinpoint Regression Program (Version 4.9.1.0). https://surveillance.cancer.gov/help/joinpoint First citation in articleGoogle Scholar

  • Plöderl, M., & Hengartner, M. P. (2019). Antidepressant prescription rates and suicide attempt rates from 2004 to 2016 in a nationally representative sample of adolescents in the USA. Epidemiology and Psychiatric Sciences, 28(5), 589–591. 10.1017/S2045796018000136 First citation in articleCrossref Medline, Google Scholar

  • Plöderl, M., Hengartner, M. P., Bschor, T., & Kaminski, J. A. (2020). Commentary to “antidepressants and suicidality: A re-analysis of the re-analysis”. Journal of Affective Disorders, 273, 252–253. 10.1016/j.jad.2020.04.025 First citation in articleCrossref Medline, Google Scholar

  • Reseland, S., Bray, I., & Gunnell, D. (2006). Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. British Journal of Psychiatry, 188(4), 354–358. 10.1192/bjp.188.4.354 First citation in articleCrossref Medline, Google Scholar

  • Safer, D. J., & Zito, J. M. (2007). Do antidepressants reduce suicide rates? Public Health, 121(4), 274–277. 10.1016/j.puhe.2006.09.024 First citation in articleCrossref Medline, Google Scholar

  • Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., & Rochester, G. (2009). Risk of suicidality in clinical trials of antidepressants in adults: Analysis of proprietary data submitted to US Food and drug Administration. BMJ, 339, Article b2880. 10.1136/bmj.b2880 First citation in articleCrossref, Google Scholar

  • Zahl, P. H., De Leo, D., Ekeberg, O., Hjelmeland, H., & Dieserud, G. (2010). The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries. BMC Psychiatry, 10, Article 62. 10.1186/1471-244X-10-62 First citation in articleCrossref Medline, Google Scholar

  • Zalsman, G., Hawton, K., Wasserman, D., Van Heeringen, K., Arensman, E., Sarchiapone, M., Carli, V., Höschl, C., Barzilay, R., Balazs, J., Purebl, G., Kahn, J. P., Sáiz, P. A., Lipsicas, C. B., Bobes, J., Cozman, D., Hegerl, U., & Zohar, J. (2016). Suicide prevention strategies revisited: 10-year systematic review. The Lancet Psychiatry, 3(7), 646–659. 10.1016/S2215-0366(16)30030-X First citation in articleCrossref Medline, Google Scholar